Search bioRxiv⌕ Search

Biology subjects

Chesnais, F.

Publications and source records attributed to Chesnais, F..

3 recordsLinked to original sources

A spatialised agent-based model of NOTCH signalling pathway in Endothelial Cells predicts emergent heterogeneity due to continual dynamic phenotypic adjustments.

Vascular Endothelial Cells (EC) plasticity is key to homeostasis and its disruption is a hallmark of diseases such as cancer, atherosclerosis, and diabetes. The EC lineage has evolved to address in parallel sensor and actuator functions. This ability is reflected in remarkable phenotypical heterogeneity of EC across different tissues, within the same tissue, and within the same vascular bed as demonstrated by single cell image analysis and transcriptomics studies. However, how the molecular signalling dynamics in EC could generate and maintain such heterogeneity in different contexts is still largely unexplored. Recently we reported that confluent EC have spatially heterogeneous NOTCH signalling pathway (NSP) levels in vitro as confirmed from analysis of available OMICS databases. Here, we show that spatial heterogeneity of NSP levels is a feature of aortic murine endothelia in vivo and recapitulated by human EC in culture despite absence of signalling from mural cells. We study lateral induction and inhibition, cis-interactions and signalling, and target genes autoregulation in NSP. Using mathematical models and experimental observations we report that NSP dynamics can generate stable, periodic, and asynchronous oscillations of the NSP target HES1. Importantly, we observe that cell contact dependent NSP signal oscillations is the most likely parsimonious mechanistic hypothesis justifying observed spatial heterogeneity in endothelia. We propose that NSP is sufficient to enable individual EC in monolayers to acquire different phenotypes dynamically explaining robustness of quiescent endothelia in performing parallel functions.

cell biology↗

Continuously perfusable, customisable and matrix-free vasculature on a chip platform.

Creating vascularised cellular environments in vitro is a current challenge in tissue engineering and a bottleneck towards developing functional stem cell-derived microtissues for regenerative medicine and basic investigations. Here we have developed a new workflow to manufacture Vasculature on Chip (VoC) systems efficiently, quickly, and inexpensively. We have employed 3D printing for fast-prototyping of bespoke VoC and coupled them with a refined organotypic culture system (OVAA) to grow patent capillaries in vitro using tissue-specific endothelial and stromal cells. Furthermore, we have designed and implemented a pocket-size flow driver to establish physiologic perfusive flow throughout our VoC-OVAA with minimal medium use and waste. Using our platform, we have created vascularised microtissues and perfused them at physiologic flow rates for extended times and observed flow-dependent vascular remodelling. Overall, we present for the first time a scalable and customisable system to grow vascularised and perfusable microtissues, a key initial step to grow mature and functional tissues in vitro. We envision that this technology will empower fast prototyping and validation of increasingly biomimetic in vitro systems, including interconnected multi-tissue systems.

bioengineering↗

A fully defined pluripotent stem cell derived multi-liver-cell model for steatohepatitis and fibrosis

Chronic liver injury, as observed in non-alcoholic steatohepatitis (NASH), progressive fibrosis, and cirrhosis, remains poorly treatable. Steatohepatitis causes hepatocyte loss in part by a direct lipotoxic insult, which is amplified by derangements in the non-parenchymal cellular (NPC) interactive network wherein hepatocytes reside, including, hepatic stellate cells, liver sinusoidal endothelial cells and liver macrophages. To create an in vitro culture model encompassing all these cells that allows studying liver steatosis, inflammation and fibrosis caused by NASH, we here developed a fully defined hydrogel microenvironment, termed hepatocyte maturation (HepMat) gel, that supports maturation and maintenance of pluripotent stem cell (PSC)-derived hepatocyte- and NPC-like cells for at least one month. The HepMat-based co-culture system modeled key molecular and functional features of TGF{beta}-induced liver fibrosis and fatty-acid induced inflammation and fibrosis better than monocultures its constituent cell populations. The novel co-culture system should open new avenues for studying mechanisms underlying liver steatosis, inflammation and fibrosis as well as for assessing drugs counteracting these effects.

bioengineering↗